1
|
Moore CB. Ebola, quarantine, and the need for a new ethical framework. J Med Ethics Hist Med 2020; 13:9. [PMID: 33117502 PMCID: PMC7575914 DOI: 10.18502/jmehm.v13i9.4078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2019] [Accepted: 06/07/2020] [Indexed: 12/02/2022] Open
Abstract
Quarantine is a broad public health strategy used to control infectious diseases outbreaks. An arguably most aggressive public health intervention, quarantine limits the asymptomatic individuals’ liberty and can result in significant harm. Quarantine was used in an attempt to control several Ebola outbreaks during the Ebola epidemic in West Africa in 2014. The most concerning quarantine intervention occurred at West Point, a slum of 75,000 people in the capital Liberian capital, Monrovia. This work critically reviews present ethical frameworks in public health for the examination of outbreaks in West Africa. This work utilizes the nine public health ethical principles described by Kerridge, Lowe and Stewart to argue that the quarantine at West Point was not ethically justified; and, it concludes that a new ethical framework for quarantine is required to address future outbreaks in the West African context.
Collapse
Affiliation(s)
- Corey Benjamin Moore
- School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
| |
Collapse
|
2
|
Shultz JM, Cooper JL, Baingana F, Oquendo MA, Espinel Z, Althouse BM, Marcelin LH, Towers S, Espinola M, McCoy CB, Mazurik L, Wainberg ML, Neria Y, Rechkemmer A. The Role of Fear-Related Behaviors in the 2013-2016 West Africa Ebola Virus Disease Outbreak. Curr Psychiatry Rep 2016; 18:104. [PMID: 27739026 PMCID: PMC5241909 DOI: 10.1007/s11920-016-0741-y] [Citation(s) in RCA: 176] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The 2013-2016 West Africa Ebola virus disease pandemic was the largest, longest, deadliest, and most geographically expansive outbreak in the 40-year interval since Ebola was first identified. Fear-related behaviors played an important role in shaping the outbreak. Fear-related behaviors are defined as "individual or collective behaviors and actions initiated in response to fear reactions that are triggered by a perceived threat or actual exposure to a potentially traumatizing event. FRBs modify the future risk of harm." This review examines how fear-related behaviors were implicated in (1) accelerating the spread of Ebola, (2) impeding the utilization of life-saving Ebola treatment, (3) curtailing the availability of medical services for treatable conditions, (4) increasing the risks for new-onset psychological distress and psychiatric disorders, and (5) amplifying the downstream cascades of social problems. Fear-related behaviors are identified for each of these outcomes. Particularly notable are behaviors such as treating Ebola patients in home or private clinic settings, the "laying of hands" on Ebola-infected individuals to perform faith-based healing, observing hands-on funeral and burial customs, foregoing available life-saving treatment, and stigmatizing Ebola survivors and health professionals. Future directions include modeling the onset, operation, and perpetuation of fear-related behaviors and devising strategies to redirect behavioral responses to mass threats in a manner that reduces risks and promotes resilience.
Collapse
Affiliation(s)
- James M. Shultz
- Center for Disaster and Extreme Event Preparedness (DEEP Center), University of Miami Miller School of Medicine, 251 174 St. #2319, Sunny Isles Beach, Miami, FL USA
| | - Janice L. Cooper
- The Carter Center, Mental Health Program Liberia, Monrovia, Liberia
| | | | - Maria A. Oquendo
- Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, NY USA
| | - Zelde Espinel
- Department of Psychiatry and Behavioral Health, University of Miami Miller School of Medicine and Jackson Memorial Hospital, Miami, FL USA
| | - Benjamin M. Althouse
- Institute for Disease Modeling, Bellevue, WA USA
- University of Washington, Seattle, WA USA
- New Mexico State University, Las Cruces, NM USA
- Santa Fe Institute, Santa Fe, NM USA
| | - Louis Herns Marcelin
- Interuniversity Institute for Research and Development (INURED), Port-au-Prince, Haiti
- Department of Anthropology, University of Miami, Coral Gables, FL USA
| | - Sherry Towers
- Simon A. Levin Mathematical, Computational and Modeling Sciences Center, Arizona State University, Tempe, AZ USA
| | - Maria Espinola
- Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH USA
| | - Clyde B. McCoy
- Department of Public Health Sciences and Comprehensive Drug Research Center, University of Miami Miller School of Medicine, Miami, FL USA
| | - Laurie Mazurik
- Department of Emergency Medicine, Sunnybrook Health Sciences Centre, Toronto, ON Canada
| | - Milton L. Wainberg
- Department of Psychiatry, Columbia University and the New York State Psychiatric Institute, New York, NY USA
| | - Yuval Neria
- Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, NY USA
| | - Andreas Rechkemmer
- Graduate School of Social Work (GSSW), University of Denver, Denver, CO USA
| |
Collapse
|
3
|
Abstract
INTRODUCTION The Ebola Virus Disease (EVD) outbreak in West Africa raised ethical issues about structural disadvantage; the duty to care of healthcare workers; the use and study of unregistered agents; the use of restrictive measures like mass quarantine and the importance of public trust. SOURCES OF DATA WHO reports, literature on EVD and ethics. AREAS OF AGREEMENT The use of restrictive measures and the testing of unregistered agents is ethical if support for individuals or communities is provided. AREAS OF CONTROVERSY Controversy exists over ethical trial design for the study of unregistered agents and over the limits of the duty to care. GROWING POINTS The role of the WHO in outbreak control and research oversight needs rethinking and further support. Solidarity in global health needs fostering. AREAS TIMELY FOR DEVELOPING RESEARCH Research is needed on how to restore and enhance health systems and public trust in EVD-affected countries.
Collapse
Affiliation(s)
- Alison K Thompson
- Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada M5S 3M2
| |
Collapse
|
4
|
Wojda TR, Valenza PL, Cornejo K, McGinley T, Galwankar SC, Kelkar D, Sharpe RP, Papadimos TJ, Stawicki SP. The Ebola Outbreak of 2014-2015: From Coordinated Multilateral Action to Effective Disease Containment, Vaccine Development, and Beyond. J Glob Infect Dis 2016; 7:127-38. [PMID: 26752867 PMCID: PMC4693303 DOI: 10.4103/0974-777x.170495] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
The Ebola outbreak of 2014-2015 exacted a terrible toll on major countries of West Africa. Latest estimates from the World Health Organization indicate that over 11,000 lives were lost to the deadly virus since the first documented case was officially recorded. However, significant progress in the fight against Ebola was made thanks to a combination of globally-supported containment efforts, dissemination of key information to the public, the use of modern information technology resources to better track the spread of the outbreak, as well as more effective use of active surveillance, targeted travel restrictions, and quarantine procedures. This article will outline the progress made by the global public health community toward containing and eventually extinguishing this latest outbreak of Ebola. Economic consequences of the outbreak will be discussed. The authors will emphasize policies and procedures thought to be effective in containing the outbreak. In addition, we will outline selected episodes that threatened inter-continental spread of the disease. The emerging topic of post-Ebola syndrome will also be presented. Finally, we will touch on some of the diagnostic (e.g., point-of-care [POC] testing) and therapeutic (e.g., new vaccines and pharmaceuticals) developments in the fight against Ebola, and how these developments may help the global public health community fight future epidemics.
Collapse
Affiliation(s)
- Thomas R Wojda
- Department of Surgery, St. Luke's University Health Network, Bethlehem, Pennsylvania and Phillipsburg, New Jersey, USA
| | - Pamela L Valenza
- Department of Family Medicine, St. Luke's University Health Network, Bethlehem, Pennsylvania and Phillipsburg, New Jersey, USA
| | - Kristine Cornejo
- Department of Family Medicine, St. Luke's University Health Network, Bethlehem, Pennsylvania and Phillipsburg, New Jersey, USA
| | - Thomas McGinley
- Department of Family Medicine, St. Luke's University Health Network, Bethlehem, Pennsylvania and Phillipsburg, New Jersey, USA
| | - Sagar C Galwankar
- Department of Emergency Medicine, University of Florida, Jacksonville, Florida, USA
| | - Dhanashree Kelkar
- Department of Emergency Medicine, University of Florida, Jacksonville, Florida, USA
| | - Richard P Sharpe
- Department of Surgery, St. Luke's University Health Network, Bethlehem, Pennsylvania and Phillipsburg, New Jersey, USA
| | - Thomas J Papadimos
- Department of Anesthesiology, The Ohio State University College of Medicine, Columbus, Ohio, USA
| | - Stanislaw P Stawicki
- Department of Surgery, St. Luke's University Health Network, Bethlehem, Pennsylvania and Phillipsburg, New Jersey, USA
| |
Collapse
|